Skip to main content

Advertisement

Log in

Electroretinogram abnormalities in FKRP-related limb–girdle muscular dystrophy (LGMDR9)

  • Original Research Article
  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

Background

Dystroglycanopathies are a heterogeneous group of membrane-related muscular dystrophies. The dystroglycanopathy phenotype includes a spectrum of severity ranging from severe congenital muscular dystrophy to adult-onset limb–girdle muscular dystrophy (LGMD). LGMDR9 is a dystroglycanopathy caused by mutations in the FKRP gene. Previous studies have characterized electroretinogram findings of dystroglycanopathy mouse models but have not been reported in humans.

Purpose

This study set out to characterize the electroretinogram in eight participants with LGMDR9.

Methods

Eight participants were recruited from an ongoing dystroglycanopathy natural history study at the University of Iowa (NCT00313677). Inclusion criteria for the current study were children and adults > 6 years old with confirmed LGMDR9. Age similar controls were identified from our electrophysiology service normative control database. Full-field electroretinograms were recorded using ISCEV standards. Six of the eight participants underwent light-adapted ON/OFF testing.

Results

The electronegative electroretinogram was not seen in any participants with LGMDR9. An unusual sawtooth pattern in the 30 Hz flicker with faster rise than descent was noted in all 8 participants. Our cases showed a decreased b-wave amplitude in light-adapted ON responses (p = 0.011) and decreased d-wave amplitude in light-adapted OFF responses (p = 0.015). Decreased b-wave amplitude in light-adapted 3.0 testing (p = 0.015) and decreased flicker ERG amplitudes were also detected (p = 0.0018). Additionally, compared to controls, participants with LGMDR9 had decreased a-wave amplitudes on dark-adapted 10 testing (p = 0.026).

Conclusions

Abnormal ON/OFF bipolar cell responses and sawtooth 30 Hz flicker waveforms on full-field electroretinogram may be specific for LGMDR9. If confirmed in a larger population and if related to disease stage, these tests are potential biomarkers which could be useful as endpoints in clinical treatment trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Muntoni F et al (2011) Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies. Curr Opin Neurol 24(5):437–442

    Article  CAS  PubMed  Google Scholar 

  2. Taniguchi-Ikeda M et al (2016) Mechanistic aspects of the formation of alpha-dystroglycan and therapeutic research for the treatment of alpha-dystroglycanopathy: A review. Mol Aspects Med 51:115–124

    Article  CAS  PubMed  Google Scholar 

  3. Kanagawa M et al (2016) Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy. Cell Rep 14(9):2209–2223

    Article  CAS  PubMed  Google Scholar 

  4. Ervasti JM, Campbell KP (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122(4):809–823

    Article  CAS  PubMed  Google Scholar 

  5. Gee SH et al (1994) Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77(5):675–686

    Article  CAS  PubMed  Google Scholar 

  6. Peng HB et al (1998) The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes Commun 5(6):475–489

    Article  CAS  PubMed  Google Scholar 

  7. Sugita S et al (2001) A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol 154(2):435–445

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sato S et al (2008) Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat Neurosci 11(8):923–931

    Article  CAS  PubMed  Google Scholar 

  9. Yoshida-Moriguchi T, Campbell KP (2015) Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology 25(7):702–713

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Montanaro F et al (1995) Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin. J Neurosci Res 42(4):528–538

    Article  CAS  PubMed  Google Scholar 

  11. Jastrow H et al (2006) Identification of a beta-dystroglycan immunoreactive subcompartment in photoreceptor terminals. Invest Ophthalmol Vis Sci 47(1):17–24

    Article  PubMed  Google Scholar 

  12. Rubio-Fernandez M et al (2018) Impairment of photoreceptor ribbon synapses in a novel Pomt1 conditional knockout mouse model of dystroglycanopathy. Sci Rep 8(1):8543

    Article  PubMed  PubMed Central  Google Scholar 

  13. Satz JS et al (2009) Visual impairment in the absence of dystroglycan. J Neurosci 29(42):13136–13146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Holzfeind PJ et al (2002) Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Largemyd mouse defines a natural model for glycosylation-deficient muscle–eye–brain disorders. Hum Mol Genet 11(21):2673–2687

    Article  CAS  PubMed  Google Scholar 

  15. Cohn RD (2005) Dystroglycan: important player in skeletal muscle and beyond. Neuromuscul Disord 15(3):207–217

    Article  PubMed  Google Scholar 

  16. Brockington M et al (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10(25):2851–2859

    Article  CAS  PubMed  Google Scholar 

  17. Beltran-Valero de Bernabé D et al (2004) Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet 41(5):e61

    Article  PubMed  Google Scholar 

  18. Esapa CT et al (2002) Functional requirements for fukutin-related protein in the Golgi apparatus. Hum Mol Genet 11(26):3319–3331

    Article  CAS  PubMed  Google Scholar 

  19. Robson AG et al (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144(3):165–177

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sustar M et al (2018) ISCEV extended protocol for the photopic On-Off ERG. Doc Ophthalmol 136(3):199–206

    Article  PubMed  PubMed Central  Google Scholar 

  21. Robson AG et al (2018) ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol 136(1):1–26

    Article  PubMed  PubMed Central  Google Scholar 

  22. Jiang X et al (2021) Prevalence of electronegative electroretinograms in a healthy adult cohort. BMJ Open Ophthalmol 6(1):e000751

    Article  PubMed  PubMed Central  Google Scholar 

  23. Thompson DA et al (2012) Retinal on-pathway deficit in congenital disorder of glycosylation due to phosphomannomutase deficiency. Arch Ophthalmol 130(6):712–719

    Article  PubMed  Google Scholar 

  24. Sieving PA (1993) Photopic ON- and OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 91:701–773

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Tremblay F et al (1994) Duchenne muscular dystrophy: negative scotopic bright-flash electroretinogram and normal dark adaptation. Can J Ophthalmol 29(6):280–283

    CAS  PubMed  Google Scholar 

  26. Jensen H et al (1995) Duchenne muscular dystrophy negative electroretinograms and normal dark adaptation. Reappraisal of assignment of X linked incomplete congenital stationary night blindness. J Med Genet 32(5):348–351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Pillers DA et al (1995) mdxCv3 mouse is a model for electroretinography of Duchenne/Becker muscular dystrophy. Invest Ophthalmol Vis Sci 36(2):462–466

    CAS  PubMed  Google Scholar 

  28. Pillers DA et al (1999) Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations. Hum Genet 105(1–2):2–9

    Article  CAS  PubMed  Google Scholar 

  29. Ricotti V et al (2016) Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system. Eur J Hum Genet 24(4):562–568

    Article  CAS  PubMed  Google Scholar 

  30. Orlandi C et al (2018) Transsynaptic binding of orphan receptor GPR179 to dystroglycan-pikachurin complex is essential for the synaptic organization of photoreceptors. Cell Rep 25(1):130-145.e5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Haro C et al (2018) Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes. Mol Vis 24:43–58

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Uribe ML et al (2021) Retinal proteomics of a mouse model of dystroglycanopathies reveals molecular alterations in photoreceptors. J Proteome Res 20(6):3268–3277

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Amanda Pfeifer provided technical assistance with creation of figures.

Funding

Ronald Keech Professorship (Drack), University of Iowa ERG fund (Drack, Pfeifer), Research to Prevent Blindness (All Authors). Natural history study (Mathews) supported by the NIH through the Iowa Wellstone Muscular Dystrophy Cooperative Research Center (U54 NS053672) and ICTS Clinical Research Unit by citing grant UL1TR002537.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Wanda Pfeifer or Arlene V. Drack.

Ethics declarations

Conflicts of interests

Not applicable.

Ethics approval

This prospective study was approved by the Institutional Review Board of the University of Iowa (IRB ID #201805774) and conformed to the requirements of the United States Health Insurance Portability and Privacy Act.

Informed consent

All subjects freely consented to participate in this study, and an informed consent was obtained from all participants included in the study.

Statement of human rights

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the University of Iowa Institutional Review Board (Approval Date: 6/18/18; IRB Approval Number: 201805774) and in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Statement on the welfare of animals

This article does not contain any studies with animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hagedorn, J.L., Dunn, T.M., Bhattarai, S. et al. Electroretinogram abnormalities in FKRP-related limb–girdle muscular dystrophy (LGMDR9). Doc Ophthalmol 146, 7–16 (2023). https://doi.org/10.1007/s10633-022-09909-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10633-022-09909-4

Keywords

Navigation